• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

How Has the Incidence of Postpartum Hemorrhage Changed Over the Past 20 Years in the US?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Corbetta-Rastelli et al. (Obstetrics and Gynecology, 2022) analyzed temporal trends in PPH and its associated risk factors

METHODS:

  • Repeated cross-sectional study
  • Population
    • Delivery hospitalizations from 2000 to 2019 in the National (Nationwide) Inpatient Sample
  • Exposures
    • PPH risk factors
  • Study design
    • The average annual percent change (AAPC) in PPH was estimated
    • Logistic regression models were performed to determine odds ratios (OR) as a measure of the association between risk factors and outcomes
  • Primary outcomes
    • Risk of PPH | PPH requiring blood transfusion | Peripartum hysterectomy in the setting of PPH

RESULTS:

  • 76.7 million delivery hospitalizations
    • PPHs: 3.0%
  • From 2000 to 2019, the rate of PPH increased
    • 2000: 2.6%
    • 2019: 4.3%
    • AAPC 2.6% (95% CI, 1.7 to 3.5)
    • Over this period, the proportion of deliveries with at least 1 PPH risk factor increased
  • 2000: 18.6%
    • 2019: 26.9%
    • AAPC 1.9% (95% CI, 1.7 to 2.0)
  • Among deliveries complicated by PPH, blood transfusions increased, followed by a decrease in the most recent decade
    • 2000: 5.4% 2011: 16.7%
    • 2019: 12.6%
  • Peripartum hysterectomy among hospitalized individuals with PPH increased, followed by a significant decrease in the final 3 years of the study period
    • 2000: 1.4% 2009: 2.4% 2016: 2.1% 2019: 0.9%
    • AAPC −27.0% (95% CI, −35.2 to −17.6)
  • Risk factors associated with PPH and transfusion, and hysterectomy in the setting of PPH were
    • Prior cesarean delivery with previa or placenta accrete
    • Placenta previa without prior cesarean
    • Antepartum hemorrhage or placental abruption
  • Individual risk factors associated with the highest odds of PPH included
    • Prior cesarean delivery with previa or placenta accreta spectrum: OR 5.58, 95% CI 5.35 to 5.81)Preeclampsia with severe features: OR 2.90 (95% CI 2.79 to 3.03)Chorioamnionitis or endometritis: OR 2.62 (95% CI 2.54 to 2.70)
    • Placenta previa without prior cesarean delivery: OR 2.39 (95% CI 2.31 to 2.47) 

CONCLUSION:

  • PPH and its associated risk factors have increased over the past 20 years
  • Despite this increase, the rates of blood transfusions and hysterectomies related to PPH have decreased in recent years
  • The authors state

This analysis supports that rising risk may be secondary to an increase in aggregate postpartum hemorrhage risk factors

The proportion of deliveries to individuals with two or more postpartum hemorrhage risk factors increased the most proportionately

Some of the overall risk is due to increasing placenta accreta spectrum, which is a global phenomenon and likely due to increasing cesarean delivery rate 

Learn More – Primary Sources:

Postpartum Hemorrhage Trends and Outcomes in the United States, 2000–2019

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Mild Thrombocytopenia: Is it a Risk Factor for Postpartum Hemorrhage?
Does Risk of Postpartum Hemorrhage Increase with Familial History of PPH?
Cochrane Review: Oxytocin to Prevent Postpartum Hemorrhage in Third Stage of Labor

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site